These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 20628836)

  • 1. Lessons from coronary intravascular ultrasound on the importance of raising high-density lipoprotein cholesterol.
    Nicholls SJ; Uno K; Tuzcu EM; Nissen SE
    Curr Atheroscler Rep; 2010 Sep; 12(5):301-7. PubMed ID: 20628836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical predictors of plaque progression despite very low levels of low-density lipoprotein cholesterol.
    Bayturan O; Kapadia S; Nicholls SJ; Tuzcu EM; Shao M; Uno K; Shreevatsa A; Lavoie AJ; Wolski K; Schoenhagen P; Nissen SE
    J Am Coll Cardiol; 2010 Jun; 55(24):2736-42. PubMed ID: 20538166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation between high density lipoprotein-cholesterol and remodeling index in patients with coronary artery disease: IDEAS (IVUS diagnostic evaluation of atherosclerosis in Singapore)-HDL study.
    Lee CH; Tai BC; Lim GH; Chan MY; Low AF; Tan KC; Chia BL; Tan HC
    Int J Cardiovasc Imaging; 2012 Jan; 28(1):33-41. PubMed ID: 21197580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lowering the triglyceride/high-density lipoprotein cholesterol ratio is associated with the beneficial impact of pioglitazone on progression of coronary atherosclerosis in diabetic patients: insights from the PERISCOPE (Pioglitazone Effect on Regression of Intravascular Sonographic Coronary Obstruction Prospective Evaluation) study.
    Nicholls SJ; Tuzcu EM; Wolski K; Bayturan O; Lavoie A; Uno K; Kupfer S; Perez A; Nesto R; Nissen SE
    J Am Coll Cardiol; 2011 Jan; 57(2):153-9. PubMed ID: 21211686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The beneficial effects of raising high-density lipoprotein cholesterol depends upon achieved levels of low-density lipoprotein cholesterol during statin therapy: Implications for coronary atheroma progression and cardiovascular events.
    Puri R; Nissen SE; Shao M; Kataoka Y; Uno K; Kapadia SR; Tuzcu EM; Nicholls SJ
    Eur J Prev Cardiol; 2016 Mar; 23(5):474-85. PubMed ID: 25691546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between LDL, HDL, blood pressure and atheroma progression in the coronaries.
    Nicholls SJ
    Curr Opin Lipidol; 2009 Dec; 20(6):491-6. PubMed ID: 19593124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of imaging end points in atherosclerosis trials: focus on intravascular ultrasound.
    Kalidindi SR; Tuzcu EM; Nicholls SJ
    Int J Clin Pract; 2007 Jun; 61(6):951-62. PubMed ID: 17504358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiographically silent atherosclerosis detected by intravascular ultrasound in patients with familial hypercholesterolemia and familial combined hyperlipidemia: correlation with high density lipoproteins.
    Hausmann D; Johnson JA; Sudhir K; Mullen WL; Friedrich G; Fitzgerald PJ; Chou TM; Ports TA; Kane JP; Malloy MJ; Yock PG
    J Am Coll Cardiol; 1996 Jun; 27(7):1562-70. PubMed ID: 8636537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atherosclerotic plaque reduction: blood pressure, dyslipidemia, atherothrombosis.
    Arora S; Nicholls SJ
    Drugs Today (Barc); 2008 Sep; 44(9):711-8. PubMed ID: 19137125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Assessment of progression and regression of coronary atherosclerosis by coronary angiography].
    Erbel R
    Herz; 2015 Sep; 40(6):875-82. PubMed ID: 26216541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravascular Ultrasound Studies of Plaque Progression and Regression: Impact of Lipid-Modifying Therapies.
    Shishikura D; Honda S; Andrews J; Nicholls SJ
    Cardiol Clin; 2018 May; 36(2):329-334. PubMed ID: 29609762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spotty calcification as a marker of accelerated progression of coronary atherosclerosis: insights from serial intravascular ultrasound.
    Kataoka Y; Wolski K; Uno K; Puri R; Tuzcu EM; Nissen SE; Nicholls SJ
    J Am Coll Cardiol; 2012 May; 59(18):1592-7. PubMed ID: 22538329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic implications of recent ATP III guidelines and the important role of combination therapy in total dyslipidemia management.
    Boden WE
    Curr Opin Cardiol; 2003 Jul; 18(4):278-85. PubMed ID: 12858126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of cholesterol metabolism on coronary plaque vulnerability of target vessels: a combined analysis of virtual histology intravascular ultrasound and optical coherence tomography.
    Nasu K; Terashima M; Habara M; Ko E; Ito T; Yokota D; Ishizuka S; Kurita T; Kimura M; Kinoshita Y; Asakura Y; Tsuchikane E; Katoh O; Suzuki T
    JACC Cardiovasc Interv; 2013 Jul; 6(7):746-55. PubMed ID: 23769651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-density lipoprotein cholesterol associated with change in coronary plaque lipid burden assessed by near infrared spectroscopy.
    Honda S; Sidharta SL; Shishikura D; Takata K; Di Giovanni GA; Nguyen T; Janssan A; Kim SW; Andrews J; Psaltis PJ; Worthley MI; Nicholls SJ
    Atherosclerosis; 2017 Oct; 265():110-116. PubMed ID: 28881268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial.
    Nissen SE; Tuzcu EM; Schoenhagen P; Brown BG; Ganz P; Vogel RA; Crowe T; Howard G; Cooper CJ; Brodie B; Grines CL; DeMaria AN;
    JAMA; 2004 Mar; 291(9):1071-80. PubMed ID: 14996776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of early atherosclerosis in de novo heart transplant recipients: analysis with intravascular ultrasound-derived radiofrequency analysis.
    König A; Kilian E; Rieber J; Schiele TM; Leibig M; Sohn HY; Reichart B; Klauss V
    J Heart Lung Transplant; 2008 Jan; 27(1):26-30. PubMed ID: 18187083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Statins, high-density lipoprotein cholesterol, and regression of coronary atherosclerosis.
    Nicholls SJ; Tuzcu EM; Sipahi I; Grasso AW; Schoenhagen P; Hu T; Wolski K; Crowe T; Desai MY; Hazen SL; Kapadia SR; Nissen SE
    JAMA; 2007 Feb; 297(5):499-508. PubMed ID: 17284700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relation between progression and regression of atherosclerotic left main coronary artery disease and serum cholesterol levels as assessed with serial long-term (> or =12 months) follow-up intravascular ultrasound.
    von Birgelen C; Hartmann M; Mintz GS; Baumgart D; Schmermund A; Erbel R
    Circulation; 2003 Dec; 108(22):2757-62. PubMed ID: 14623804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Remnant cholesterol, coronary atheroma progression and clinical events in statin-treated patients with coronary artery disease.
    Elshazly MB; Mani P; Nissen S; Brennan DM; Clark D; Martin S; Jones SR; Quispe R; Donnellan E; Nicholls SJ; Puri R
    Eur J Prev Cardiol; 2020 Jul; 27(10):1091-1100. PubMed ID: 31744333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.